facebook
twitter
rss
account
search
search
 

FDA OKs Plavix to prevent cardiac death

Sept. 8, 2006 at 7:03 PM   |   Comments

NEW YORK, Sept. 8 (UPI) -- Bristol-Myers Squibb and Sanofi said Friday the U.S. Food and Drug Administration has OK'd Plavix to prevent fatal heat attack.

The companies said FDA approved expanded use of the anti-clotting drug to reduce the risk of death from any cause and the risk of a combined endpoint of recurrent heart attack, stroke or death in patients with acute STEMI.

STEMI is the most severe form of heart attack and is marked by complete blockage of an artery, the companies said.

Patients who have survived a STEMI incident are at higher risk of another heart attack, stroke or death. More than 300,000 people in the United States experience a STEMI heart attack each year, the companies said.

© 2006 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
Notable deaths of 2014 [PHOTOS]

Notable deaths of 2014 [PHOTOS]

Most Popular
1
Daughters more likely than sons to care for elder parents
2
India asks Pepsi to cut down on sugar in its soft drinks
3
Child vaccination rates are high, CDC says
4
Yoga guru BKS Iyengar dies at 95
5
NIH to test safety of Ebola vaccine candidate
Trending News
Video
x
Feedback